NCT04494204View on ClinicalTrials.gov

Effect of a Combination of Treatment of Reginmune Capsule and Immunofree Tablets in the Treatment of Mild to Moderate COVID-19 Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 7, 2020

Primary Completion Date

December 1, 2020

Study Completion Date

December 20, 2020

Conditions
Treatment of Covid-19 Virus Infection
Interventions
COMBINATION_PRODUCT

Immunofree tablets and Reginmune capsule

2 Immunofree tablets thrice a day at an interval of 4-5 hours for 10 days and 1 Reginmune capsule twice a day for 10 days

Trial Locations (3)

391760

Parul Institute of Ayurveda and Research Parul University, Vadodara

411033

Lokmanya Hospital, Pune

532001

Govt Medical College and Govt General Hospital (Old RIMSGGH), Srikakulam

All Listed Sponsors
lead

PUNEET MITTAL

NETWORK

NCT04494204 - Effect of a Combination of Treatment of Reginmune Capsule and Immunofree Tablets in the Treatment of Mild to Moderate COVID-19 Patients | Biotech Hunter | Biotech Hunter